Subcutaneous Bortezomib Plus Melphalan and Prednisone (VMP) in Non-Transplant Eligible Newly Diagnosed Multiple Myeloma (MM) Patients: Spanish Experience

Saved in:
Bibliographic Details
Published inClinical lymphoma, myeloma and leukemia Vol. 15; pp. e135 - e136
Main Authors De Arriba, F, Vidal, S, Duran, S, Alvarez, M.A, Lopez San Roman, I, Dios, A, Rios, R, S. Gonzalez, M, Prieto, E, Garcia, R, Barez, A, Escalante, E, Clavero, C, Tejedor, A, Capote, F.J, Cabañas, V, Ballesteros, M, Couto, C, Zamudio, G, Mateos, M.V
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.09.2015
Subjects
Hematology, Oncology and Palliative Medicine
Online AccessGet full text

Cover

More Information
ISSN:2152-2650
2152-2669
DOI:10.1016/j.clml.2015.07.333